[{"Assets_0_Q2_USD":78627000.0,"CommonStockSharesOutstanding_0_Q2_shares":45172632.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-19468000.0,"NetIncomeLoss_1_Q2_USD":-12624000.0,"NetIncomeLoss_2_Q2_USD":-13829000.0,"StockholdersEquity_0_Q2_USD":42906000.0,"Ticker":"CDMO","CIK":"704562","name":"PEREGRINE PHARMACEUTICALS INC","OfficialName":"Avid Bioservices Inc. Common Stock","form":"10-Q","period":"20171031","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1130539049.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171211"}]